Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · March 21, 2021

Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure

Circulation: Heart Failure

 

Additional Info

Circulation: Heart Failure
Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Controlled Study
Circ Heart Fail 2021 Mar 01;14(3)e007048, S Tamaki, T Yamada, T Watanabe, T Morita, Y Furukawa, M Kawasaki, A Kikuchi, T Kawai, M Seo, M Abe, J Nakamura, K Yamamoto, K Kayama, M Kawahira, K Tanabe, K Fujikawa, M Hata, Y Fujita, Y Umayahara, S Taniuchi, S Sanada, A Shintani, M Fukunami

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading